Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 62

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 3
Chunk 62
---
 by pending patent applications, or that we or our licensors, were
the first to file patent applications for such inventions. Additionally, the grant and enforceability of a patent is dependent on a number
of factors that may vary between jurisdictions. These factors may include the novelty of the invention, the requirement that the invention
not be obvious in the light of prior art (including prior use or publication of the invention), the utility of the invention and the extent
to which the patent clearly describes the best method of working the invention. In short, this means that claims granted in various territories
may vary and thereby influence commercial outcomes.

While we have applied for
and will continue to file for protection as appropriate for our therapeutic products and technologies, we cannot be certain that any future
patent applications we file, or licensed to us, will be granted, or that we will develop additional proprietary products or processes
that are patentable or that we will be able to license any other patentable products or processes. We cannot be certain that others will
not independently develop similar products or processes, duplicate any of the products or processes developed or being developed by the
company or licensed to us, or design around the patents owned or licensed by us, or that any patents owned or licensed by us will provide
us with competitive advantages.

Furthermore, we cannot be
certain that patents held by third parties will not prevent the commercialization of products incorporating the technology developed by
us or licensed to us, or that third parties will not challenge or seek to narrow, invalidate or circumvent any of the issued, pending
or future patents owned or licensed by us.

Our commercial success will
also depend, in part, on our ability to avoid infringement of patents issued to others. If a court determines that we were infringing
any third-party patents, we could be required to pay damages, alter our products or processes, obtain licenses or cease certain activities.
We cannot be certain that the licenses required under patents held by third parties would be made available on terms acceptable to us
or at all. To the extent that we are unable to obtain such licenses, we could be foreclosed from the development, export, manufacture
or commercialization of the product requiring such license or encounter delays in product introductions while we attempt to design around
such patents, and any of these circumstances could have a material adverse effect on our business, financial condition and results of
operations. We may have to resort to litigation to enforce any patents issued or licensed to us or to determine